Follikuláris limfóma: vizsgálatok itt: Egyesült Államok
103 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisCsak meghívásosCD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Where
- Baltimore
- Életkor
- 18 év and over
- People
- 15
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT07168486 - 1. fázisTaking peopleRituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Where
- Cleveland
- Életkor
- 18 év and over
- People
- 15
- Run by
- Paolo Caimi, MD
See details and how to joinNCT07225439 - 2. fázisTaking peopleA Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
- Where
- Houston
- Életkor
- 18 év and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06043323 - 2. fázisTaking peopleOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 27
- Run by
- University of Washington
See details and how to joinNCT06784726 - 2. fázisTaking peopleLow Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 20
- Run by
- University of Washington
See details and how to joinNCT06442475 - 1/2. fázisTaking peopleStudy of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Where
- Albuquerque, Allentown, Augusta, Buffalo, Cincinnati, Cleveland, Dallas, Denver, Grand Rapids, Hackensack, Indianapolis, Iowa City, Irvine, Los Angeles, Louisville, Milwaukee, Nashville, New York, Norfolk, Omaha, Philadelphia, Pittsburgh, Richmond, Salt Lake City, San Antonio, San Diego, Shreveport, The Bronx, Washington D.C., Winston-Salem
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Lyell Immunopharma, Inc.
See details and how to joinNCT05826535 - 1/2. fázisTaking peopleEpcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
- Where
- Columbus, Minneapolis, Richmond
- Életkor
- 18 év and over
- People
- 38
- Run by
- Yazeed Sawalha
See details and how to joinNCT06536049 - 2. fázisTaking peopleMosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
- Where
- New Brunswick, New Haven, Providence
- Életkor
- 18 év and over
- People
- 52
- Run by
- Brown University
See details and how to joinNCT04792502 - 1. fázisTaking peopleAutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Where
- Palo Alto
- Életkor
- 18 év and over
- People
- 148
- Run by
- Stanford University
See details and how to joinNCT06340737 - 2. fázisTaking peopleHM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
- Where
- Minneapolis
- Életkor
- 18 év and over
- People
- 65
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT06792825 - 2. fázisTaking peopleA Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Where
- Basking Ridge, Commack, Hackensack, Harrison, Middletown, Montvale, New York, Rockville Centre, Washington D.C.
- Életkor
- 18 év and over
- People
- 152
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05389293 - 1. fázisTaking peopleLV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Where
- Milwaukee
- Életkor
- 18 év to 81 év
- People
- 12
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05990465 - No phaseTaking peopleSample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
- Where
- Austin
- Életkor
- 18 év and over
- People
- 200
- Run by
- Natera, Inc.
See details and how to joinNCT07750886 - 1. fázisTaking peopleThis is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Where
- Buffalo, Duarte, Nashville, New York, Seattle, St Louis
- Életkor
- 18 év and over
- People
- 42
- Run by
- LTZ Therapeutics, Inc.
See details and how to joinNCT07121946 - 1. fázisNot yet taking people in Egyesült ÁllamokEpcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
- Where
- Los Angeles
- Életkor
- 70 év and over
- People
- 20
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07714421 - 1. fázisTaking peopleImmune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
- Where
- Chicago, Columbus, Duarte, New York, Philadelphia, Salt Lake City, The Bronx
- Életkor
- 18 év and over
- People
- 20
- Run by
- AIDS Malignancy Consortium
See details and how to joinNCT05077527 - 2. fázisTaking peopleOdronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
- Where
- Sacramento
- Életkor
- 18 év and over
- People
- 34
- Run by
- University of California, Davis
See details and how to joinNCT06854159 - No phaseTaking peopleEvaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 200
- Run by
- Emory University
See details and how to joinNCT03501576 - 2. fázisTaking peopleAllo HSCT Using RIC and PTCy for Hematological Diseases
- Where
- Minneapolis
- Életkor
- Up to 75 év
- People
- 56
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Atlanta, Bethesda, Chicago, Cincinnati, Cleveland, Denver, Duarte, Durham, Houston, Ithaca, Miami, Milwaukee, New Haven, New York, Philadelphia, Salt Lake City, San Francisco, Sarasota
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - No phaseTaking peopleCombating Cancer-Related Fatigue: A Personalized Supportive Care Program
- Where
- Chapel Hill
- Életkor
- 18 év and over
- People
- 40
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06860880 - 2. fázisTaking peopleEpcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
- Where
- Sacramento
- Életkor
- 18 év and over
- People
- 25
- Run by
- University of California, Davis
See details and how to joinNCT06905509 - No phaseTaking peopleRegistry of Older Patients With Cancer
- Where
- Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
- Életkor
- 65 év and over
- People
- 3000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825 - 2. fázisTaking peopleMyeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Where
- Minneapolis
- Életkor
- Up to 60 év
- People
- 300
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974 - 2. fázisTaking peoplePirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 22
- Run by
- University of Washington
See details and how to joinNCT06948786